Parasomnia induced by lemborexant: a case report
Toshinori Nakamura1, Yusuke Arai1, Tetsuya Hagiwara1
1Departments of Psychiatry.
International Clinical Psychopharmacology
|March 11, 2024
Summary
Lemborexant (an orexin receptor antagonist) may cause abnormal sleep behaviors like parasomnia in some patients, distinct from delirium. Discontinuing the medication led to rapid symptom improvement.
Area of Science:
- Neurology
- Sleep Medicine
- Pharmacology
Background:
- Lemborexant, an orexin receptor antagonist, is recognized for treating sleep disorders and delirium.
- Complex sleep-related behaviors (parasomnias) have not been previously associated with lemborexant use.
Observation:
- A 69-year-old male patient with oral cancer developed delirium post-surgery.
- Following an increased dosage of lemborexant for insomnia, the patient exhibited abnormal nocturnal behaviors.
Findings:
- The abnormal nocturnal behavior rapidly resolved upon cessation of lemborexant.
- The observed symptoms suggest a potential link between increased lemborexant dosage and parasomnia, differentiating it from delirium.
Implications:
- Distinguishing lemborexant-induced parasomnia from delirium is crucial due to differing treatment strategies.
- Clinicians should consider parasomnia when patients display novel abnormal behaviors after lemborexant dosage adjustments.
Related Concept Videos
Management of Insomnia
768
The sleep cycle, an integral part of human health, consists of several stages with distinct characteristics and functions. It begins with a transition from wakefulness to sleep, known as the light sleep phase, followed by the restorative deep sleep phase, essential for physical recovery and growth. The cycle concludes with the Rapid Eye Movement (REM) phase, characterized by high brain activity and vivid dreaming. Insomnia, a prevalent sleep disorder, involves difficulty falling asleep, staying...
768
Sedatives and Hypnotics Drugs: Miscellaneous Agents
960
Sedatives and hypnotics encompass a wide range of substances, each with its unique mechanism of action, uses, and potential adverse effects.
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
960
Sleepwalking and Sleep Talking
1.8K
Somnambulism, commonly known as sleepwalking, involves individuals engaging in activities ranging from simple walking to more complex behaviors such as driving. Sleepwalking typically occurs during the slow-wave sleep stages 3 and 4 early in the night when the person is not dreaming, contradicting the myth that sleepwalkers are acting out their dreams.
Factors that increase the likelihood of sleepwalking include sleep deprivation and alcohol consumption. Contrary to common beliefs, it is safe...
Factors that increase the likelihood of sleepwalking include sleep deprivation and alcohol consumption. Contrary to common beliefs, it is safe...
1.8K
REM Sleep Behavior Disorder
2.9K
REM Sleep Behavior Disorder (RBD) is a sleep disorder characterized by the absence of muscle paralysis that normally occurs during the REM phase of sleep. This absence allows individuals to physically act out their dreams, which are often vivid and disturbing. Common behaviors exhibited during episodes include kicking, punching, and yelling. These actions can be dangerous, potentially leading to injuries for the person with RBD or their bed partner.
RBD is significantly associated with...
RBD is significantly associated with...
2.9K
Restless Leg Syndrome and Night Terrors
926
Restless Leg Syndrome (RLS), also known as Willis-Ekbom disease, is a neurological disorder characterized by an uncontrollable urge to move the legs due to uncomfortable sensations. These sensations typically occur during periods of rest or inactivity, particularly when lying down or sitting, and can severely disrupt sleep.
The exact cause of RLS is not fully understood, but it is believed to involve dopamine, a neurotransmitter that helps regulate muscle movement. Imbalances in dopamine levels...
The exact cause of RLS is not fully understood, but it is believed to involve dopamine, a neurotransmitter that helps regulate muscle movement. Imbalances in dopamine levels...
926
Narcolepsy
887
Narcolepsy is a chronic sleep disorder characterized by pervasive, uncontrolled sleepiness and other sleep disturbances. One of its hallmark symptoms is an abrupt transition to REM sleep upon falling asleep, which causes symptoms typically associated with this phase to occur unexpectedly during wakefulness. These include the following symptoms, which typically last from a minute or two to half an hour.
887


